Integra LifeSciences Acquires Surgical Innovation Associates (SIA)

Solventum Completes Acquisition of Acera Surgical

December 23, 2025

Healthcare Services

Solventum completed its acquisition of Acera Surgical, a privately held bioscience company focused on regenerative wound care. The deal includes $725 million in upfront cash plus up to $125 million in contingent cash payments tied to future milestones.

Integra LifeSciences Acquires Acclarent, Inc.

April 1, 2024

Medical Devices

Integra LifeSciences Holdings Corporation has completed its acquisition of Acclarent, Inc., a maker of ear, nose and throat (ENT) surgical devices. The transaction expands Integra’s product portfolio into the ENT device segment, adding approximately $1 billion to the company’s total addressable market and providing scale through Acclarent’s commercial and R&D capabilities.

Bimini Health Tech Subsidiary Acquires Ideal Implant, Inc. Assets

August 17, 2023

Medical Devices

A newly formed subsidiary of Bimini Health Tech acquired substantially all assets of Ideal Implant, Inc., including intellectual property, regulatory approvals (FDA Class III for the breast implant), inventory and certain manufacturing capacity. The acquisition adds the Serene Breast Implant to Bimini’s plastic and reconstructive surgery portfolio and is intended to reposition the technology for the hospital setting to drive growth.

Henry Schein Signs Definitive Agreement to Acquire S.I.N. Implant System

May 4, 2023

Medical Devices

Henry Schein has signed an agreement to acquire S.I.N. Implant System, a Brazilian dental implant manufacturer, pending regulatory approval. The deal is expected to close in the latter half of 2023, subject to approval by Brazil’s Administrative Council for Economic Defense (CADE).

INSA Corp. Acquires Integra Data Systems Corp.

April 13, 2023

Cybersecurity

INSA Corp., a Canadian IT network security reseller, has acquired Integra Data Systems Corp., a Greater Toronto Area technology solutions provider. Terms were not disclosed; the deal expands INSA's geographic footprint and technical capabilities across government, education and enterprise customers in Ontario.

Integra LifeSciences Acquires ACell, Inc.

December 16, 2020

Medical Devices

Integra LifeSciences agreed to acquire regenerative-medicine company ACell, Inc. for $300 million upfront in cash plus up to $100 million in revenue-based milestones. The acquisition adds ACell's MatriStem porcine urinary bladder matrix platform to Integra's tissue technologies portfolio and is expected to close in Q1 2021, subject to customary conditions.